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Background: Understanding of repeat human immunodeficiency virus
(HIV) testing (RHT) is limited and the impact of rural residence as a po-
tential barrier to RHT is unknown. Rural populations are of particular
interest in the Southeastern United States because of their dispropor-
tionate HIV burden.
Methods: We used HIV surveillance data from publicly funded HIV
testing sites in North Carolina to assess repeat testing by transmission
risk group and residential rurality in a retrospective cohort study.
Linear binomial regression models were used to estimate adjusted, 1-year
cumulative incidences and cumulative incidence differences comparing
RHTwithin transmission risk populations by level of rurality.
Results: In our total study population of 600,613 persons, 19,275 (3.2%)
and 9567 (1.6%) self-identified asmen who have sex with men (MSM) and
persons who inject drugs (PWID), respectively. A small minority, 13,723
(2.3%) resided in rural ZIP codes. Men who have sex with men were most
likely to repeat test (unadjusted, 1-year cumulative incidence after an initial
negative test, 16.4%) compared with PWID (13.2%) and persons who did
not identify as either MSMor PWID (13.6%). The greatest effect of rurality
was within PWID; the adjusted, 1-year cumulative incidence of RHTwas
6.4 (95% confidence interval, 1.4–11.4) percentage points higher among
metropolitan versus rural PWID.
Conclusions: One-year cumulative incidence of RHTwas low among all
clients of publicly funded HIV testing sites in North Carolina, including
MSM and PWID for whom annual testing is recommended. Our findings
suggest a need for public health efforts to increase access to and support
for RHT, particularly among rural PWID.
An estimated 15% of persons living with human immunodefi-ciency virus (HIV) (PLWH) in the United States remain un-
aware of their infection,1 despite national recommendations that
those at high risk of infection be tested at least annually.2,3 High-
risk populations include persons who inject drugs (PWID) and
their sex partners, persons who practice transactional sex, sex part-
ners of PLWH, men who have sex with men (MSM), and persons
who are infected with or are seeking testing for sexually transmit-
ted infections.2,3 Regular HIV testing allows for early detection of
infection and serves as the gateway to care, treatment, and viral
suppression.1,4 However, current understanding of testing patterns
is based on analyses restricted to cross-sectional data, self-reported
testing histories, and/or individual risk groups.5–9
Residence in a rural area is an important barrier to HIV test-
ing among at-risk populations due to transportation challenges, re-
duced numbers or availability of nearby HIV testing sites, and
increased perceived stigma toward PLWH.10,11 Although rural
populations test later in the HIV disease course and have lower
lifetime and past-year testing prevalences than urban popula-
tions,10,12 little is known about repeat HIV testing behaviors by ru-
rality. Any effects of rurality on repeat HIV testing may be
especially relevant in the Southeastern United States, where the
proportion of the rural population living with HIV is 3 times that
of other regions.13
We conducted a surveillance-based analysis of HIV test-
ing patterns and the effects of rurality on repeat testing in North
Carolina (NC), where 20% of new HIV diagnoses occur in rural
regions, compared with 8.9% of new diagnoses across the
United States.14 We aimed to characterize the 1-year cumulative
incidence of repeat HIV testing by transmission risk group and
to estimate the effect of rurality on repeat HIV testing within
each population.
MATERIALS AND METHODS
Study Design, Setting, and Population
We conducted a retrospective cohort study of adults with a
negative result on an initial (index) HIV test at any publicly funded
testing site in NC between July 2005 and December 2012, exam-
ining surveillance records in the subsequent year to estimate the
cumulative incidence of a secondHIV test at a publicly funded site
within 1 year of the index test.
Data were drawn from the NC Division of Public Health
Counseling, Testing, and Referral Services (CTRS) database,
which tracks conventional (non–point-of-care) HIV tests per-
formed at 199 publicly funded testing sites in NC. These sites in-
clude health departments—which house HIV testing sites and
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STD, family planning, and obstetrics & gynecology clinics—as
well as community-based organizations, community health cen-
ters, drug treatment facilities, and county jails. The CTRS database
contains data on more than 200,000 unique tests each year and is
used for program planning and surveillance at the state level.
The CTRS data include test setting and client-reported demo-
graphics, residential ZIP code and county, HIV testing history, risk
factors for HIV infection, and reasons for testing. These data are
recorded by HIV testing personnel and sent to the NC State Labo-
ratory of Public Health for entry into the CTRS database. Testing
events between July 1, 2005, and December 31, 2013, were linked
by unique client in a prior study,15 allowing reconstruction of indi-
vidual testing histories.
We excluded testing clients who reported being pregnant at
the index test because NC prenatal care guidelines require opt-out
HIV testing at the first visit and during the third trimester of preg-
nancy,16 and our interest was in repeat testing behaviors outside of
this context. We also excluded clients who did not report a ZIP code
and county of residence in NC at the index test, clients with a pos-
itive result on the index test, pediatric clients (age, < 18 years) and
those missing age, and clients with an index test after December
31, 2012.
Outcome, Exposure, and Covariate Definitions
Our outcome of interest was repeat testing, which we de-
fined as any HIV test captured by CTRSwithin 1 year after the in-
dex test to correspond with annual testing recommendations.2,3
Outcome assessment was based only on the first repeat test, be-
cause the intent of the current analysis was only to determine
whether testing occurred again within a year; description of
longitudinal testing patterns will be the focus of future work.
We relaxed the assessment period to 15 months in a sensitivity
analysis to allow flexibility in assessing testing guideline ad-
herence. In the main analysis, we included repeat tests per-
formed in the context of pregnancy to avoid censoring by the
competing risk of pregnancy. We performed an additional sen-
sitivity analysis to assess the impact of this decision, excluding
all repeat tests conducted during a reported pregnancy or at a
pregnancy/obstetrics testing site.
We based the main exposure, rurality of residence, on
client-reported residential ZIP code at the index test, collapsing
the US Department of Agriculture’s 2010 Rural-urban Commut-
ing Areas (RUCA) classifications17 into metropolitan (RUCA
score, 1–3), micropolitan (RUCA score, 4–9), and rural (RUCA
score, 10). The RUCA scheme classifies census tracts into 10
levels of rurality/urbanicity based on measures of population den-
sity, urbanization, and daily commuting, and then further assigns
rurality at the ZIP code level according to census tract classifica-
tions within each ZIP code. In a sensitivity analysis, we assigned
rurality of residence based on residential county under the 2013
NCHS Urban-rural Classification Scheme.18 This framework clas-
sifies counties according to the Office of Management and Budget's
2013 delineation of metropolitan and micropolitan statistical areas
within each county. We collapsed the Urban-rural Classification
Scheme scores in an analogous manner to the RUCA classifications
defined above as metropolitan, micropolitan, and rural.
All stratification and confounder variables were generated
from client-reported values at the index test. We created 4 risk
group categories according to MSM and PWID status: clients
identifying asMSM but not PWID (MSM-only), clients identifying
as PWID but not MSM (PWID-only), clients identifying as both
MSM and PWID (MSM+ PWID), and clients not identifying as ei-
ther MSM or PWID (neither MSM nor PWID). In multivariable
models (see below), we dichotomized gender as female and
male because there were no rural testers who identified as trans-
gender. We coded race/ethnicity with disjoint indicators as
white/non-Hispanic, black/non-Hispanic, Hispanic, Asian or
Pacific Islander/non-Hispanic, Native American/non-Hispanic,
and other/multiracial, with white/non-Hispanic serving as the
referent group. Age was represented with linear and quadratic
terms in multivariable models.
Statistical Analyses
We first examined covariate distributions overall and by the
full set of 4 transmission risk groups (MSM-only, PWID-only,
MSM + PWID, neither MSM nor PWID). Due to small numbers
ofMSM+ PWID, we conducted all subsequent analyses with a re-
duced set of 3 transmission risk group categories: MSM, PWID,
and neither MSM nor PWID. Clients who reported being both
MSM and PWID (MSM + PWID) were included both as MSM
in analyses restricted to MSM and as PWID in analyses restricted
to PWID.
We calculated unadjusted 1-year cumulative incidences of
repeat testing in each of the transmission risk groups in our re-
duced set (MSM, PWID, and neither MSM nor PWID) by rurality
of residence and several relevant covariates. To assess the effect of
rurality on repeat testing within each group, we then constructed
distinct linear binomial regression models tailored to each popula-
tion. We selected minimum sufficient adjustment sets using di-
rected acyclic graphs19 after a comprehensive literature review,
adjusting for age and race/ethnicity in the model restricted to
MSM; for age, race/ethnicity, gender, and MSM status in the
model restricted to PWID; and for age, race/ethnicity, and gender
Figure 1. Application of inclusion and exclusion criteria to form
study population. Of 858,501 testing clients, we excluded
pediatric clients and those missing age, clients with an index test
after December 31, 2012, clients with a positive result on the
index test, clients who reported being pregnant at the index test,
and clients who did not report a NC ZIP code and county of
residence at the index test, for a total of 600,613 included clients.
in the model restricted to neither MSM nor PWID. These models
were used to estimate the adjusted, 1-year cumulative incidences
and 95% confidence intervals (95% CIs) of repeat HIV testing
by level of rurality within each population, along with the corre-
sponding cumulative incidence differences (CIDs) and 95% CIs
comparing micropolitan and rural residents (separately) to metro-
politan residents within each population.
The institutional review board at the University of North
Carolina at Chapel Hill approved this secondary analysis of public
health surveillance data. All statistical analyses were conducted in
SAS 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
Of 858,501 persons testing during the study period,
600,613 were eligible for analysis (Fig. 1). The majority were female
(57%) (Table 1). Clients in the “neitherMSMnor PWID” groupwere
most likely to be black/non-Hispanic (46%), whereas MSM-only,
PWID-only, and MSM + PWID clients were most likely to be
white/non-Hispanic. The PWID-only clients tended to be older com-
pared with other testing populations, and the percentage of white/
non-Hispanic clients was particularly high (70%) in this popula-
tion. Testing site type varied widely across risk groups, although
STD testing and treatment sites accounted for the largest number
of index tests in each group. Most repeat tests across all risk groups
occurred at the same testing site type as a client's initial test. A large
majority of all clients resided in metropolitan ZIP codes at index
testing, with slightly larger proportions of MSM-only, PWID-only,
and MSM + PWID clients residing in metropolitan areas compared
with neither MSM nor PWID clients.
Men who have sex with men and PWIDmade up 3.2% and
1.6% of testing clients, with MSM + PWID clients contributing to
both populations. Transmission risk group, including MSM and
PWID status, was missing for 8.3% of male clients and 10.0%
of all clients, respectively, suggesting underreporting of these
identifiers. No other substantial missingness was present.
In univariate analyses, 16.4% of MSM clients returned for
repeat testing within 1 year of index testing compared with
TABLE 1. Characteristics by Transmission Risk Group of Persons Undergoing an HIV Test at Publicly Funded Testing Sites in North Carolina at













Male 18,252 (100) 4642 (55) 1023 (100) 234,214 (41) 258,131 (43)
Female 0 (0) 3755 (45) 0 (0) 334,469 (59) 338,224 (57)
Transgender† 0 (0) 1 (0) 0 (0) 131 (0) 132 (0)
Race/ethnicity
White, non-Hispanic 8598 (49) 5790 (70) 474 (48) 189,012 (35) 203,874 (36)
Black, non-Hispanic 6423 (37) 1841 (22) 376 (38) 251,104 (46) 259,744 (45)
Hispanic 2012 (12) 510 (6) 124 (13) 89,298 (16) 91,944 (16)
Asian/Pacific Islander 230 (1) 43 (1) 5 (1) 7924 (2) 8202 (1)
American Indian/Alaska
Native
156 (1) 112 (1) 6 (1) 7284 (1) 7558 (1)
Other/multiracial 17 (0) 7 (0) 0 (0) 644 (0) 668 (0)
Age, y
18–24 7843 (43) 2310 (27) 344 (34) 232,117 (41) 242,614 (40)
25–34 5129 (28) 2728 (32) 301 (29) 174,227 (30) 182,385 (30)
35–44 2868 (16) 1803 (21) 176 (17) 92,327 (16) 97,174 (16)
≥ 45 2412 (13) 1703(20) 202 (20) 74,123 (13) 78,440 (13)
Initial testing site
LHD/CBO 2516 (15) 644 (8) 70 (7) 30759 (6) 33989 (6)
STD testing and treatment 8878 (51) 2310 (28) 517 (53) 25,4954 (47) 266,659 (47)
Drug treatment 206 (1) 1471 (18) 54 (6) 7710 (1) 9441 (2)
Family planning/sexual
health
158 (1) 660 (8) 2 (0) 119,769 (22) 120,589 (21)
CHC/PHC 638 (4) 220 (3) 30 (3) 16,166 (3) 17,054 (3)
Jail 362 (2) 1341 (16) 63 (7) 34,200 (6) 35,966 (6)
Other 4631 (27) 1572 (19) 232 (24) 80,690 (15) 87,125 (15)
Repeat test at same site type‡
Yes 6572 (97) 2901 (98) 356 (98) 207,637 (99) 595,786 (99)
No 204 (3) 62 (2) 8 (2) 1104 (1) 4827 (1)
Rurality of residence
Metropolitan 15,194 (83) 6833 (80) 813 (80) 435,531 (76) 458,371 (76)
Micropolitan 2827 (16) 1491 (18) 186 (18) 124,015 (22) 128,519 (21)
Rural 231 (1) 220 (3) 24 (2) 13,248 (2) 13,723 (2)
Repeat HIV testing
No repeat test 11,476 (63) 5581 (65) 659 (64) 364,053 (64) 381,769 (64)
Repeat test ≤ 1 y 3361 (18) 1247 (15) 142 (14) 88,106 (15) 92,856 (16)
Repeat test > 1 y 3415 (19) 1716 (20) 222 (22) 120,635 (21) 125,988 (21)
Total 18,252 8544 1023 572,794 600,613
*Missing values are not included in calculation of percentage.
†Includes male-to-female and female-to-male transgender clients.
‡Includes first repeat test following the index test, regardless of time elapsed between tests. Percentage is out of only those with at least 1 repeat test.
LHD/CBO, local health department/community-based organization; CHC/PHC, community health center/primary health care.
13.2% of PWID clients and 13.6% of neither MSM nor PWID cli-
ents.We refer the reader to Supplemental Table 1 (http://links.lww.
com/OLQ/A270) for a summary of these cumulative incidences
by selected covariates.
Across all subpopulations of interest, metropolitan MSM
and PWID clients were most likely to return for repeat testing (ad-
justed, 1-year cumulative incidence, 0.170; 95% CI, 0.16–0.18 in
both populations) and rural PWID clients were the least likely (ad-
justed, 1-year cumulative incidence, 0.102; 95% CI, 0.05–0.15)
(Table 2). Among MSM, rural and micropolitan clients showed
adjusted, 1-year cumulative incidences of repeat testing that were
2.4 (95% CI, −2.0 to 6.8) and 3.2 (95% CI, 1.9–4.6) percentage
points lower than those of their metropolitan peers, respectively.
Similar trends were observed among PWID and neither MSM
nor PWID. The greatest effect of rurality on repeat testing was
within PWID; the 1-year cumulative incidence of repeat testing
was 6.4 (95% CI, 1.4–11.4) percentage points lower among rural
versus metropolitan PWID.
Sensitivity analyses allowing 15 months of observation
showed slightly larger adjusted cumulative incidences of repeat
testing across all populations and levels of rurality (Supplemental
Table 2, http://links.lww.com/OLQ/A270), reflecting an uptick in
repeat testing between 12 and 15 months (Supplemental Figure
1, http://links.lww.com/OLQ/A270). The increased cumulative in-
cidences were smaller among PWID than the other testing popula-
tions. Cumulative incidence differences in the 15-month analyses
were very similar to those in the main analyses. Sensitivity analy-
ses with rurality assigned by county of residence at the index test
shifted approximately 4% of clients from the micropolitan classi-
fication to both the metropolitan and rural classifications and
yielded effect estimates within approximately 1 percentage point
of the absolute effect estimates identified in the primary analyses
(Supplemental Table 3, http://links.lww.com/OLQ/A270). A final
sensitivity analysis excluding all repeat tests that occurred during
pregnancy or were conducted at pregnancy/obstetrics testing sites
showed slightly lower cumulative incidences among PWID and
neither MSM nor PWID clients, but CIDs were again similar to
the main results (Supplemental Table 4, http://links.lww.com/
OLQ/A270).
DISCUSSION
Although regular HIV testing among at-risk groups is es-
sential to maximize clinical and public health benefits, little is
known about repeat HIV testing based on objective measures
across multiple risk groups, and the effect of rurality as a potential
barrier to HIV testing is unknown. In this study, we examined
these measures and effects using surveillance data from publicly
funded testing sites in a large, diverse population. Despite recom-
mended annual testing for all high-risk individuals, including
MSM and PWID,2,3 the 1-year cumulative incidence of repeat test-
ing in our setting was only 16% among MSM and 13% among
PWID. After inclusion of repeat tests that occurred within
15 months of the index test, cumulative incidence remained sub-
optimal (21% among MSM and 18% among PWID). These re-
sults indicate a clear need for public health efforts to increase
access to and support for regular HIV testing in NC.
The rural/urban disparities that we observed in repeat HIV
testing mirror disparities that have been identified previously with
other HIV testing metrics.11–14,20–24 Lifetime testing prevalence
estimates range from 43.6% among residents of the most urban
areas of the United States to 32.2% among residents of the most
rural areas, whereas past-year testing prevalence ranges from
13.5% to 7.3% in those areas, respectively.14 Of note, our esti-
mated 1-year cumulative incidences of testing among persons
who had already had a negative HIV test are slightly higher at
all rurality levels than corresponding past-year estimates calcu-
lated irrespective of prior testing status,14 suggesting that previ-
ously reported rural-urban disparities in testing prevalences and
disease stage at diagnosis14,23 may be largely due to differences
in first-time testing behaviors rather than repeating testing behav-
iors. Although repeat HIV testing should be encouraged among all
at-risk clients, our results indicate that interventions aiming to re-
duce rural-urban disparities within the full population may be best
targeted toward introduction of new rural testing clients to the
existing HIV testing infrastructure in NC.
Although metropolitan MSM clients were more likely to
repeat-test within 1 year than any other testing population, the
1-year cumulative incidence of repeat HIV testing among MSM
clients in NC across all levels of rurality was lower than might
be expected from previous estimates. In 1 study among HIV-
uninfected Black MSM ages 18 to 30 years in NC, 83% reported
ever receiving an HIV test. Among those subjects who had previ-
ously tested, 71% of this particularly at-risk population reported
testing at least once every 6 months and 40% reported testing at
least quarterly.8 Further, 21% of a sample of MSM with HIV-
negative primary partners in the United States reported testing at
least once every 6 months and 29% reported testing at least once
per year.11 The apparent discrepancies between our results and
those of prior studies may be due to differences in study popula-
tions and measures, our capture of only those tests performed at
publicly-funded testing sites, and/or earlier studies' reliance on
self-reported HIV testing.
Although rural and micropolitan populations represent a
minority of the total, at-risk, and testing populations in NC, the
substantial burden placed on rural areas by the recent opioid
TABLE 2. Adjusted 1-y Cumulative Incidence of Repeat HIV Testing within Transmission Risk Group of Persons Undergoing an HIV Test at Publicly
Funded Testing Sites in North Carolina by Rurality of Zip Code of Residence at First (Index) Visit, 2005–2012





(95% CI) CID (95% CI)§
Cumulative
Incidence
(95% CI) CID (95% CI)§
Cumulative
Incidence
(95% CI) CID (95% CI)§
Metropolitan 0.17 (0.16–0.18) — 0.17 (0.16–0.18) — 0.16 (0.15–0.16) —
Micropolitan 0.14 (0.13–0.15) −0.03 (−0.05 to −0.02) 0.13 (0.11–0.15) −0.03 (−0.05, −0.01) 0.14 (0.13–0.14) −0.02 (−0.02 to −0.02)
Rural 0.15 (0.10–0.19) −0.02 (−0.07 to 0.02) 0.10 (0.05–0.15) −0.06 (−0.11, −0.01) 0.11 (0.11–0.12) −0.04 (−0.04 to −0.04)
Unadjusted total 0.164 0.132 0.136
*Model conducted only among MSM (including MSM + PWID) clients and adjusts for age and race/ethnicity.
†Model conducted only among PWID (including MSM + PWID) clients and adjusts for age, race/ethnicity, gender, and MSM status.
‡Model conducted only among neither MSM nor PWID clients and adjusts for age, race/ethnicity, and gender.
§Referent group is metropolitan clients within transmission risk group (MSM, PWID, or neither MSM nor PWID).
epidemic heightens the need for improved understanding of rural
HIV testing behaviors, especially among PWID. Only 10% of
PWID in rural areas in our setting returned for repeat testing
within a year of their index test, a substantially smaller percentage
compared with their metropolitan peers. This difference may be
due to greater accessibility of resources for PWID in metropolitan
compared with micropolitan, and particularly, rural areas. A lack
of harm reduction resources for PWID, including HIV testing,
has previously been linked to anomalous HIV outbreaks in rural
areas,25 highlighting the potential hazard of infrequent HIV testing
among rural PWID.
More generally, the low 1-year cumulative incidence of re-
peat testing observed among PWID overall underscores a need for
increased repeat HIV testing among PWID in NC, regardless of
region of residence. To this end, the 2016 legalization of syringe
service programs in NC offers improved opportunities to reach
PWID with harm reduction services, including HIV testing.26 Al-
though we did not examine hepatitis C virus (HCV) testing, our re-
sults may have similar implications for the provision of HCV
testing, which has substantial overlap with HIV testing in NC. In-
tegration of point-of-care HIV and HCV testing into syringe ser-
vice programs, just as these tests have already been introduced
into many other nontraditional HIV testing sites, could improve
early detection and treatment of both diseases among the high-
risk PWID populations served by these programs. Integration of
services may be particularly beneficial in rural regions where
transportation is an obstacle to accessing testing and other harm
reduction resources.24
Our reliance on CTRS data results in underestimation of
the true 1-year cumulative incidence of repeat testing because sec-
ondary tests performed outside of publicly funded testing sites in
NC and point-of-care secondary tests are not captured. There is a
clear need for increased collaboration, including data sharing, be-
tween public and private organizations offering testing services to
fully characterize HIV testing patterns in NC. The reliance on
CTRS data may also bias rurality effect estimates if the likelihood
of receiving a secondary test at a publicly versus privately funded
testing site is related to rurality. In 1 prior study, residents of rural
areasweremore likely to report testing in a hospital, whereas residents
of urban areas were more likely to report testing at publicly funded
testing centers.12 Exclusion of persons with missing age or county/
ZIPof residencemay have resulted in some selection bias, but it is dif-
ficult to speculate on the magnitude or direction of any such bias.
Substantial missing data for both MSM and PWID risk be-
haviors indicate that both factors were likely underreported, poten-
tially in part due to stigma, which limits inference from our
findings in these groups to those who disclose MSM and PWID
status to testing personnel. One recent study of acute HIV cases di-
agnosed in NC showed substantially increased reporting of MSM
behaviors after diagnosis compared with reporting at the time of
testing,27 supporting the likelihood that some MSM and PWID
were misclassified in our analysis as not belonging to either group.
Additionally, the small number of rural MSM and PWID clients
resulted in comparatively imprecise estimates among these sub-
populations, and we were unable to separately examine repeat
testing in the population of MSM + PWID clients. Further, this
analysis is unable to distinguish between true first-time testing
and those who had received HIV tests at publicly funded testing
sites prior to initiation of data collection, as well as confirmatory
repeat testing. Only 1.5% of repeat tests occurred within 1 month
of the index test, suggesting that testers seeking confirmation of
prior negative results had a minimal effect on our estimates. Fi-
nally, CTRS data are limited in scope and were collected for sur-
veillance rather than research. Thus, there may be uncontrolled
confounding by variables not available in the database, including
socioeconomic status. The restricted nature of CTRS data also
limited us to evaluating populations of testing clients in broad
strokes instead of by more nuanced individual risk factors
for infection.
One-year cumulative incidence of repeat HIV testing was
low among all clients of publicly funded testing centers in NC, in-
cluding populations of MSM and PWID in whom annual testing
is recommended. This study also suggests that the effect of rural-
ity on 1-year cumulative incidence of repeat HIV testing is sub-
stantively small overall and among MSM in North Carolina.
However, this effect is slightly more pronounced within PWID.
There is a need for increased repeat HIV testing, as well as
general STD screening, across all at-risk testing populations in
NC, with perhaps the greatest need among rural populations
of PWID.
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